Phenol denatures proteins, while chloroform strengthens the separation between the organic and aqueous phases. Together, these solvents shift unwanted cellular material away from the nucleic-acid-containing aqueous fraction. This division is central to purification because it reduces protein, lipid, and other cellular contamination before the recovered nucleic acids are concentrated for later molecular biology work.
After centrifugation, nucleic acids generally remain in the aqueous layer, whereas many unwanted components are removed with the organic phase or separated material. Recovering the appropriate fraction preserves the target DNA or RNA while limiting carryover. The recovered aqueous solution can then undergo alcohol-and-salt precipitation, producing nucleic acids suitable for subsequent analysis.
Residual phenol or chloroform can inhibit downstream reactions, even when the nucleic-acid fraction has been recovered. Solvent carryover therefore affects more than sample cleanliness: it can compromise procedures such as PCR, cloning, sequencing, or gene-expression analysis. Careful handling and attention to phase recovery are important for obtaining a usable nucleic acid preparation.
An overall workflow begins with an aqueous biological mixture, followed by treatment that allows phenol to denature proteins and chloroform to promote phase separation. Centrifugation then separates the phases, and the aqueous fraction is recovered. Finally, alcohol and salt are used to precipitate the nucleic acids. Each stage supports removal, separation, or concentration.
It is useful when biological samples contain proteins, lipids, and other cellular components that must be removed from DNA or RNA. The resulting nucleic acids can support cloning, PCR, sequencing, and gene-expression analysis. Thus, the method fits workflows that require purified genetic material rather than an unfractionated cellular extract.
Phenol and chloroform are hazardous, so the procedure requires careful handling. Quality also depends on preventing residual solvent from remaining with the recovered nucleic acids, because carryover can inhibit later reactions. These safety and cleanup considerations are inseparable from the biological objective: obtaining DNA or RNA that can perform reliably in downstream molecular applications.